BrainGuard

📍 Madrid, Spain🗓 Founded 2017👥 3 employees💰 Last funded Jan 2018
BrainGuard is the first company that predicts in an objective, accurate and personalized way the onset of a migraine by unobtrusive monitoring of hemodynamic signals. BrainGuard helps migraineurs letting them know in advance of the onset of a migraine to act and avoid the pain improving their quality of life. To change the paradigm of the disease, BrainGuard provides a personalized disease treatment based on prescriptions of their trusted doctor.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BrainGuard?
BrainGuard has 1 investors on record on gritt.io, including 1 early-stage backers.
When did BrainGuard last raise funding?
The most recent investment in BrainGuard recorded on gritt.io was in January 2018.
When was BrainGuard founded?
BrainGuard was founded in 2017.
What industry is BrainGuard in?
BrainGuard operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BrainGuard based?
BrainGuard is headquartered in Madrid, Spain.